1 Answers
Intravitreal (Adult)-
Neovascular (wet) age-related macular degeneration: 0.5 mg mthly into the affected eye as a single dose. Continue treatment until visual acuity is stable for 3 consecutive mth. Doses are given at intervals of at least 1 mth.
Choroidal neovascularisation secondary to pathologic myopia: 0.5 mg into the affected eye as a single dose. Further injections may be given if monitoring reveals signs of disease activity (1 inj during the 1st yr; some patients may need more frequent treatment). Doses are given at intervals of at least 1 mth.
Diabetic macular oedema, Macular oedema secondary to retinal vein occlusion: 0.5 mg mthly into the affected eye as a single dose. Continue treatment until visual acuity is stable for 3 consecutive mth. Doses are given at intervals of at least 1 mth. Discontinue treatment if no improvement in visual acuity after 3 initial inj.
লুসেন্টিস অন্তঃসত্ত্বা ইনজেকশন সম্পর্কে বিস্তারিত জেনে নিন এই লিঙ্ক থেকে লুসেন্টিস